Patents by Inventor Masashi Ishigami
Masashi Ishigami has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20150352095Abstract: The present invention provides a tetomilast crystal that is industrially easily produced in a large volume. (1) a tetomilast hydrate crystal having a power X-ray diffraction spectrum that is substantially the same as the powder X-ray diffraction spectrum shown in FIG. 2; (2) an anhydrous tetomilast type A crystal having a powder X-ray diffraction spectrum that is substantially the same as the powder X-ray diffraction spectrum shown in FIG. 4; (3) an anhydrous tetomilast type C crystal having a powder X-ray diffraction spectrum that is substantially the same as the powder X-ray diffraction spectrum shown in FIG. 8; (4) a tetomilast acetonitrile solvate crystal having a powder X-ray diffraction spectrum that is substantially the same as the powder X-ray diffraction spectrum shown in FIG. 10; and (5) a mixture consisting of the above anhydrous tetomilast type A crystal and an anhydrous tetomilast type B crystal.Type: ApplicationFiled: August 19, 2015Publication date: December 10, 2015Applicant: OTSUKA PHARMACEUTICAL CO., LTD.Inventors: Satoshi AOKI, Kenji NAKAYA, Masahiro SOTA, Masashi ISHIGAMI
-
Patent number: 9145404Abstract: The present invention provides a tetomilast crystal that is industrially easily produced in a large volume. (1) a tetomilast hydrate crystal having a power X-ray diffraction spectrum that is substantially the same as the powder X-ray diffraction spectrum shown in FIG. 2; (2) an anhydrous tetomilast type A crystal having a powder X-ray diffraction spectrum that is substantially the same as the powder X-ray diffraction spectrum shown in FIG. 4; (3) an anhydrous tetomilast type C crystal having a powder X-ray diffraction spectrum that is substantially the same as the powder X-ray diffraction spectrum shown in FIG. 8; (4) a tetomilast acetonitrile solvate crystal having a powder X-ray diffraction spectrum that is substantially the same as the powder X-ray diffraction spectrum shown in FIGS. 10; and (5) a mixture consisting of the above anhydrous tetomilast type A crystal and an anhydrous tetomilast type B crystal.Type: GrantFiled: December 31, 2013Date of Patent: September 29, 2015Assignee: OTSUKA PHARMACEUTICAL CO., LTD.Inventors: Satoshi Aoki, Kenji Nakaya, Masahiro Sota, Masashi Ishigami
-
Patent number: 8993601Abstract: The present invention provides a tetomilast crystal that is industrially easily produced in a large volume. (1) a tetomilast hydrate crystal having a power X-ray diffraction spectrum that is substantially the same as the powder X-ray diffraction spectrum shown in FIG. 2; (2) an anhydrous tetomilast type A crystal having a powder X-ray diffraction spectrum that is substantially the same as the powder X-ray diffraction spectrum shown in FIG. 4; (3) an anhydrous tetomilast type C crystal having a powder X-ray diffraction spectrum that is substantially the same as the powder X-ray diffraction spectrum shown in FIG. 8; (4) a tetomilast acetonitrile solvate crystal having a powder X-ray diffraction spectrum that is substantially the same as the powder X-ray diffraction spectrum shown in FIG. 10; and (5) a mixture consisting of the above anhydrous tetomilast type A crystal and an anhydrous tetomilast type B crystal.Type: GrantFiled: March 4, 2013Date of Patent: March 31, 2015Assignee: Otsuka Pharmaceutical Co., Ltd.Inventors: Satoshi Aoki, Kenji Nakaya, Masahiro Sota, Masashi Ishigami
-
Publication number: 20140113937Abstract: The present invention provides a tetomilast crystal that is industrially easily produced in a large volume. (1) a tetomilast hydrate crystal having a power X-ray diffraction spectrum that is substantially the same as the powder X-ray diffraction spectrum shown in FIG. 2; (2) an anhydrous tetomilast type A crystal having a powder X-ray diffraction spectrum that is substantially the same as the powder X-ray diffraction spectrum shown in FIG. 4; (3) an anhydrous tetomilast type C crystal having a powder X-ray diffraction spectrum that is substantially the same as the powder X-ray diffraction spectrum shown in FIG. 8; (4) a tetomilast acetonitrile solvate crystal having a powder X-ray diffraction spectrum that is substantially the same as the powder X-ray diffraction spectrum shown in FIGS. 10; and (5) a mixture consisting of the above anhydrous tetomilast type A crystal and an anhydrous tetomilast type B crystal.Type: ApplicationFiled: December 31, 2013Publication date: April 24, 2014Applicant: Otsuka Pharmaceutical Co., Ltd.Inventors: Satoshi AOKI, Kenji NAKAYA, Masahiro SOTA, Masashi ISHIGAMI
-
Patent number: 8501949Abstract: The present invention provides a tetomilast crystal that is industrially easily produced in a large volume. (1) a tetomilast hydrate crystal having a powder X-ray diffraction spectrum that is substantially the same as the powder X-ray diffraction spectrum shown in FIG. 2; (2) an anhydrous tetomilast type A crystal having a powder X-ray diffraction spectrum that is substantially the same as the powder X-ray diffraction spectrum shown in FIG. 4; (3) an anhydrous tetomilast type C crystal having a powder X-ray diffraction spectrum that is substantially the same as the powder X-ray diffraction spectrum shown in FIG. 8; (4) a tetomilast acetonitrile solvate crystal having a powder X-ray diffraction spectrum that is substantially the same as the powder X-ray diffraction spectrum shown in FIG. 10; and (5) a mixture consisting of the above anhydrous tetomilast type A crystal and an anhydrous tetomilast type B crystal.Type: GrantFiled: March 15, 2007Date of Patent: August 6, 2013Assignee: Otsuka Pharmaceutical Co., Ltd.Inventors: Satoshi Aoki, Kenji Nakaya, Masahiro Sota, Masashi Ishigami
-
Publication number: 20100222590Abstract: The present invention provides a tetomilast crystal that is industrially easily produced in a large volume. (1) a tetomilast hydrate crystal having a powder X-ray diffraction spectrum that is substantially the same as the powder X-ray diffraction spectrum shown in FIG. 2; (2) an anhydrous tetomilast type A crystal having a powder X-ray diffraction spectrum that is substantially the same as the powder X-ray diffraction spectrum shown in FIG. 4; (3) an anhydrous tetomilast type C crystal having a powder X-ray diffraction spectrum that is substantially the same as the powder X-ray diffraction spectrum shown in FIG. 8; (4) a tetomilast acetonitrile solvate crystal having a powder X-ray diffraction spectrum that is substantially the same as the powder X-ray diffraction spectrum shown in FIG. 10; and (5) a mixture consisting of the above anhydrous tetomilast type A crystal and an anhydrous tetomilast type B crystal.Type: ApplicationFiled: March 15, 2007Publication date: September 2, 2010Inventors: Satoshi Aoki, Kenji Nakaya, Masahiro Sota, Masashi Ishigami
-
Patent number: 4101626Abstract: An article expanded at the center portion and having the maximum diameter at said portion, for example a ball-shaped flexible tube joint, is produced by using a mold consisting of a main mold having the same inner surface as the outer shape of said article, a cover mold provided with an elastic core having the same outer shape as the inner shape of the above described article and provided with a hollow cavity in the inside of the core, and a bottom mold provided with a projection, which detachably fits in the hollow cavity in the core, the main mold being put between the cover mold and the bottom mold, and a cavity having the same shape as the article to be molded being formed by the cover mold, the elastic core, the main mold and the bottom mold, and by pouring a liquid elastomer into the thus formed cavity and hardening said liquid elastomer.Type: GrantFiled: February 18, 1977Date of Patent: July 18, 1978Assignee: Bridgestone Tire Company LimitedInventors: Takuya Takahashi, Masashi Ishigami